Biogen, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 1.58%154.250.0%$2827.12m
BNGOBioNano Genomics, Inc. -6.14%11.460.0%$2363.68m
GILDGilead Sciences, Inc. -0.08%66.651.0%$654.85m
AMGNAmgen, Inc. 0.00%258.601.3%$584.65m
REGNRegeneron Pharmaceuticals, Inc. 0.00%544.102.7%$497.98m
ALXNAlexion Pharmaceuticals, Inc. -0.19%161.452.0%$474.46m
ILMNIllumina, Inc. 0.00%420.553.5%$443.81m
CRSPCRISPR Therapeutics AG -3.03%164.400.6%$432.09m
NVAXNovavax, Inc. 0.00%127.1692.9%$407.11m
VRTXVertex Pharmaceuticals, Inc. 0.00%237.641.9%$379.54m
SRPTSarepta Therapeutics, Inc. -0.32%92.3513.8%$342.30m
BIIBBiogen, Inc. 0.00%271.671.7%$323.61m
BNTXBioNTech SE 0.67%107.000.0%$310.00m
EXASEXACT Sciences Corp. 0.00%141.0419.6%$251.66m
EDITEditas Medicine, Inc. -1.09%60.027.5%$195.96m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.